Published in Medical Verdicts and Law Weekly, April 12th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Teva Pharmaceutical Industries Ltd..
Report 1: Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) reported results for the quarter and the full year ended December 31, 2006.
Net sales for the fourth quarter of 2006 increased 63% to $2,277 million, compared to $1,401 million in the fourth quarter of 2005. The main contributors to the growth in sales for the quarter were the inclusion of Ivax sales, which benefited all regions, and new products sold in the U.S. that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly